Idera Pharmaceuticals
Idera Pharmaceuticals (Nasdaq:IDRA) is engaged in the discovery and development of synthetic DNis a and RNA-based compounds for the treatment of cancer, infectious diseases, autoimmune diseases, and asthma/allergies, and for use as vaccine adjuvants.
RSS Headlines
Fool UK